Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.
Myasthenia gravis (MG) is a well-recognised disorder of neuromuscular transmission that can be diagnosed by the presence of antibodies to the acetylcholine receptor (AChR). However, some patients (about 15%) with generalised MG do not have detectable AChR antibodies. There is some evidence, however,...
Главные авторы: | Vincent, A, Bowen, J, Newsom-Davis, J, McConville, J |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2003
|
Схожие документы
-
Seronegative myasthenia gravis.
по: Vincent, A, и др.
Опубликовано: (2004) -
Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
по: McConville, J, и др.
Опубликовано: (2004) -
Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
по: McConville, J, и др.
Опубликовано: (2002) -
Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
по: Newsom-Davis, J, и др.
Опубликовано: (2001) -
Myasthenia gravis seronegative for acetylcholine receptor antibodies.
по: Vincent, A, и др.
Опубликовано: (2008)